Recent progress in the 3D printing of microneedle patches for biomedical applications.

Int J Pharm

Key Laboratory of Cluster Science of Ministry of Education, Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering of Ministry of Industry and Information Technology, School of Chemistry and Chemical Engineering, Beijing Institute of Technology, 100081 Beijing, China. Electronic address:

Published: January 2025

AI Article Synopsis

  • 3D-printed microneedles (MNs) are a game-changing technology for drug delivery and diagnostics, offering a less invasive alternative to traditional methods.
  • The review covers advancements in 3D printing techniques such as FDM, DLP, and SLA, allowing for customized MN designs that enhance drug delivery and biosensing.
  • Despite their promise, challenges like regulatory issues, biocompatibility of materials, and scaling up manufacturing need to be addressed for 3D-printed MNs to transform healthcare successfully.

Article Abstract

3D-printed microneedles (MNs) have emerged as a transformative technology in drug delivery, diagnostics, and cosmetics, providing a minimally invasive alternative to traditional methods. This review highlights the advancements in 3D printing technologies, including fused deposition modeling (FDM), digital light processing (DLP), and stereolithography (SLA), which enable the precise fabrication of MNs with customizable geometries and functionalities. The unique ability of MNs to penetrate the stratum corneum facilitates enhanced delivery of therapeutic agents, biosensing capabilities, and improved patient compliance. Recent innovations in MNs design, such as biomimetic structures and optimized geometries, have significantly improved their mechanical properties and drug delivery efficiency. Furthermore, integrating sensing elements within MNs enables real-time monitoring of biomarkers, paving the way for personalized medicine. Despite the promising applications, challenges remain, including regulatory considerations, material biocompatibility, and manufacturing scalability. This review discusses the current state of 3D-printed MNs, their diverse applications, and future directions. By addressing existing limitations and exploring novel materials and hybrid fabrication techniques, 3D-printed MNs have the potential to revolutionize healthcare delivery and improve patient outcomes.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijpharm.2024.124995DOI Listing

Publication Analysis

Top Keywords

drug delivery
8
3d-printed mns
8
mns
7
progress printing
4
printing microneedle
4
microneedle patches
4
patches biomedical
4
biomedical applications
4
applications 3d-printed
4
3d-printed microneedles
4

Similar Publications

Competing endogenous RNAs network dysregulation in oral cancer: a multifaceted perspective on crosstalk and competition.

Cancer Cell Int

December 2024

Laboratory of Stem Cell Regulation with Chinese Medicine and Its Application, School of Pharmacy, Hunan University of Chinese Medicine, Changsha, Hunan, 410208, China.

Oral cancer progresses from asymptomatic to advanced stages, often involving cervical lymph node metastasis, resistance to chemotherapy, and an unfavorable prognosis. Clarifying its potential mechanisms is vital for developing effective theraputic strategies. Recent research suggests a substantial involvement of non-coding RNA (ncRNA) in the initiation and advancement of oral cancer.

View Article and Find Full Text PDF

Green tea has garnered increasing attention across age groups due to its numerous health benefits, largely attributed to Epigallocatechin 3-gallate (EGCG), its key polyphenol. EGCG exhibits a wide spectrum of biological activities, including antioxidant, anti-inflammatory, antibacterial, anticancer, and neuroprotective properties, as well as benefits for cardiovascular and oral health. This review provides a comprehensive overview of recent findings on the therapeutic potential of EGCG in various human diseases.

View Article and Find Full Text PDF

Upregulated YTHDC1 mediates trophoblastic dysfunction inducing preterm birth in ART conceptions through enhanced RPL37 translation.

Cell Mol Life Sci

December 2024

The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, 910# Hengshan Road, Shanghai, China.

Assisted reproductive technology (ART) pregnancies present a higher risk of singleton preterm birth than natural pregnancies, but the underlying molecular mechanism remains largely unknown. RNA mA modification is a key epigenetic mechanism regulating cellular function, but the role of mA modification, especially its "reader" YTHDC1, in preterm delivery remains undefined. To delineate the role and epigenetic mechanism of mA modification in ART preterm delivery, the effects of YTHDC1 on trophoblastic function were evaluated by CCK-8, EdU, Transwell, and flow cytometry analyses post its overexpression or knockdown.

View Article and Find Full Text PDF

Approved natural products-derived nanomedicines for disease treatment.

Chin J Nat Med

December 2024

School of Science, China Pharmaceutical University, Nanjing 2111198, China. Electronic address:

In recent years, there has been an increasing emphasis on exploring innovative drug delivery approaches due to the limitations of conventional therapeutic strategies, such as inadequate drug targeting, insufficient therapeutic efficacy, and significant adverse effects. Nanomedicines have emerged as a promising solution with notable advantages, including extended drug circulation, targeted delivery, and improved bioavailability, potentially enhancing the clinical treatment of various diseases. Natural products/materials-derived nanomedicines, characterized by their natural therapeutic efficacy, superior biocompatibility, and safety profile, play a crucial role in nanomedicine-based treatments.

View Article and Find Full Text PDF

Disulfiram impairs USP21-mediated MOF-K257 deubiquitination to inhibit esophageal squamous cell carcinoma progression.

Cancer Lett

December 2024

Department of Thoracic Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China; Key Laboratory of Precision Diagnosis and Treatment of Lung Tumors in Shandong Provincial Medicine and Health, Shandong University, Jinan, China; Key Laboratory of Basic Research and Clinical Transformation of Thoracic Tumors in Shandong Provincial Colleges and Universities, Shandong University, Jinan, China. Electronic address:

Disulfiram (DSF), primarily applied in the therapy for alcohol addiction, has been demonstrated to possess the promising capability of anti-tumor in many human cancers, including esophageal squamous cell carcinoma (ESCC). To date, almost all studies about DSF in ESCC are focusing on investigating either drug combinations or nanoparticle-based delivery systems. However, the exact molecular mechanisms mediating the response to DSF in ESCC are totally unknown.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!